Yuh-jin Liang
Taipei, TNQ, Taiwan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Unravelling the heterogeneous HCC risk in indeterminate chronic hepatitis B.
Journal: Gut
Published: July 29, 2025
The impact of single-nucleotide variants of hepatitis B virus and antiviral on liver cancer in gray zone patients.
Journal: Journal of biomedical science
Published: April 02, 2025
YULINK deficiency promotes cell death under glucose restriction in HCC cells in association with GLUT1-mediated glycolysis.
Journal: Molecular medicine (Cambridge, Mass.)
Published: March 18, 2025
Antiviral therapy reduces hepatocellular carcinoma through suppressing hepatitis B virus replication may improve ER stress, mitochondrial and metabolic dysfunctions and decrease p62 in hybridized mice with single HBV transgene and miR-122.
Journal: Journal of medical virology
Published: June 28, 2023
Gene coexpression network analysis identifies hubs in hepatitis B virus-associated hepatocellular carcinoma.
Journal: Journal of the Chinese Medical Association : JCMA
Published: July 08, 2022
Glycosphingolipids in human embryonic stem cells and breast cancer stem cells, and potential cancer therapy strategies based on their structures and functions.
Journal: Glycoconjugate journal
Published: September 25, 2021
Clinical Implications of HBV PreS/S Mutations and the Effects of PreS2 Deletion on Mitochondria, Liver Fibrosis, and Cancer Development.
Journal: Hepatology (Baltimore, Md.)
Published: November 16, 2020
Lymphoid Enhancer Factor 1 Contributes to Hepatocellular Carcinoma Progression Through Transcriptional Regulation of Epithelial-Mesenchymal Transition Regulators and Stemness Genes.
Journal: Hepatology communications
Published: January 19, 2018
Last Updated: 09/26/2026